Ken Griffin Frequency Therapeutics, Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$0.35 - $0.72 $2,800 - $5,760	-8,000 Reduced 76.92%	2,400 $0
Q2 2023 Aug 14, 2023	SELL	$0.33 - $0.48 $7,161 - $10,416	-21,700 Reduced 67.6%	10,400 $3,000
Q1 2023 May 15, 2023	SELL	$0.44 - $5.47 $3,036 - $37,743	-6,900 Reduced 17.69%	32,100 $16,000
Q4 2022 Feb 14, 2023	SELL	$1.88 - $3.85 $306,252 - $627,165	-162,900 Reduced 80.68%	39,000 $150,000
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $118,406 - $206,805	-81,100 Reduced 28.66%	201,900 $361,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.